These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 6743518)

  • 21. [Effects of inhaled beta-adrenergic and anticholinergic drugs on respiratory function and arterial blood gases in patients with pulmonary emphysema].
    Igarashi T; Nishimura M; Akiyama Y; Yamamoto M; Kobayashi S; Miyamoto K; Kawakami Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Jan; 31(1):32-6. PubMed ID: 8096880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decrease of PaO2 during exercise in patients with emphysema and lung fibrosis. Evidence for different intrapulmonary diffusive resistances.
    Magnussen H; Hartmann V; Holle JP
    Bull Eur Physiopathol Respir; 1979; 15(1):153-61. PubMed ID: 465817
    [No Abstract]   [Full Text] [Related]  

  • 23. Arterial endothelin-1 level in pulmonary emphysema and interstitial lung disease. Relation with pulmonary hypertension during exercise.
    Yamakami T; Taguchi O; Gabazza EC; Yoshida M; Kobayashi T; Kobayashi H; Yasui H; Ibata H; Adachi Y
    Eur Respir J; 1997 Sep; 10(9):2055-60. PubMed ID: 9311502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome.
    Cottin V; Le Pavec J; Prévot G; Mal H; Humbert M; Simonneau G; Cordier JF;
    Eur Respir J; 2010 Jan; 35(1):105-11. PubMed ID: 19643948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The alveolar-arterial oxygen difference in chronic obstructive lung disease.
    Mellemgaard K
    Scand J Respir Dis; 1967; 48(1):23-39. PubMed ID: 5183051
    [No Abstract]   [Full Text] [Related]  

  • 26. Impact of chronic obstructive pulmonary disease with pulmonary hypertension on both left ventricular systolic and diastolic performance.
    Yilmaz R; Gencer M; Ceylan E; Demirbag R
    J Am Soc Echocardiogr; 2005 Aug; 18(8):873-81. PubMed ID: 16084341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conditions associated with severe carbon monoxide diffusion coefficient reduction.
    Kiakouama L; Cottin V; Glerant JC; Bayle JY; Mornex JF; Cordier JF
    Respir Med; 2011 Aug; 105(8):1248-56. PubMed ID: 21454061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of pulmonary artery remodeling on pulmonary circulation after lung volume reduction surgery.
    Haniuda M; Kubo K; Fujimoto K; Honda T; Yamaguchi S; Yoshida K; Amano J
    Thorac Cardiovasc Surg; 2003 Jun; 51(3):154-8. PubMed ID: 12833205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pulmonary emphysema: quantification using computed tomography and correlations with respiratory function tests].
    Daghfous J; Beji M; Kanoun N; Mouelhi M; Tabka Z; Agrebi L; Hamza R
    Rev Mal Respir; 1993; 10(4):299-305. PubMed ID: 8235021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension.
    Mereles D; Ehlken N; Kreuscher S; Ghofrani S; Hoeper MM; Halank M; Meyer FJ; Karger G; Buss J; Juenger J; Holzapfel N; Opitz C; Winkler J; Herth FF; Wilkens H; Katus HA; Olschewski H; Grünig E
    Circulation; 2006 Oct; 114(14):1482-9. PubMed ID: 16982941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary hypertension in rats with papain emphysema.
    Herget J; Palecek F; Cermáková M; Vízek M
    Respiration; 1979; 38(4):204-12. PubMed ID: 523827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.
    Lewis GD; Shah R; Shahzad K; Camuso JM; Pappagianopoulos PP; Hung J; Tawakol A; Gerszten RE; Systrom DM; Bloch KD; Semigran MJ
    Circulation; 2007 Oct; 116(14):1555-62. PubMed ID: 17785618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pulmonary arterial hypertension on exertion during syndromes of essential chronic bronchitis complicated or not by emphysema].
    Perrin-Fayolle M; Kofman J; Cassan G; Gardère J; Brun J
    J Fr Med Chir Thorac; 1971; 25(2):129-43. PubMed ID: 5553093
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical characteristics and prediction of pulmonary hypertension in severe emphysema.
    Minai OA; Fessler H; Stoller JK; Criner GJ; Scharf SM; Meli Y; Nutter B; DeCamp MM;
    Respir Med; 2014 Mar; 108(3):482-90. PubMed ID: 24290900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The relations between intra-alveolar pressure and pulmonary arterial pressure in silicotic emphysema].
    Cai KC
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1985 Aug; 8(4):230-2, 256. PubMed ID: 4075930
    [No Abstract]   [Full Text] [Related]  

  • 36. [Respiratory activity in pulmonary emphysema patients].
    Tetenev FF
    Ter Arkh; 1968 Nov; 40(11):29-35. PubMed ID: 5746738
    [No Abstract]   [Full Text] [Related]  

  • 37. [Rehabilitation of respiration in outbreaks of bronchial superinfection].
    Litomericky S; Kristufek P; Litomericka M
    Poumon Coeur; 1977; 33(1):29-32. PubMed ID: 876962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The alveolo-arterial oxygen tension difference at varying alveolar ventilation in patients with pulmonary disease breathing air.
    Refsum HE; Kim BM
    Clin Sci; 1967 Dec; 33(3):569-76. PubMed ID: 6078520
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pulmonary circulation in chronic pneumopathies].
    Denolin H
    Poumon Coeur; 1966; 22(7):793-810. PubMed ID: 5958631
    [No Abstract]   [Full Text] [Related]  

  • 40. Changes in transcutaneous oxygen tension during exercise in pulmonary emphysema.
    Hughes JA; Gray BJ; Hutchison DC
    Thorax; 1984 Jun; 39(6):424-31. PubMed ID: 6431626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.